Puma Biotechnology Inc’s filing revealed that its Former Officer Ludwig Jeffrey Jerome acquired Company’s shares for reported $0.19 million on May 21 ’25. In the deal valued at $3.42 per share,55,882 shares were bought.
Then, NOUGUES MAXIMO F sold 10,227 shares, generating $32,232 in total proceeds. Upon selling the shares at $3.15, the Chief Financial Officer now owns 152,295 shares.
Before that, Ludwig Jeffrey Jerome sold 9,437 shares. Puma Biotechnology Inc shares valued at $29,743 were divested by the Chief Commercial Officer at a price of $3.15 per share. As a result of the transaction, Ludwig Jeffrey Jerome now holds 108,951 shares, worth roughly $0.36 million.
Citigroup upgraded its Puma Biotechnology Inc [PBYI] rating to a Buy from a a Neutral in a research note published recently. Goldman also remained covering PBYI and has decreased its forecast on October 08, 2019 with a “Sell” recommendation from previously “Neutral” rating. Citigroup revised its rating on May 10, 2019. It rated PBYI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PBYI
On Tuesday, Puma Biotechnology Inc [NASDAQ:PBYI] saw its stock jump 0.91% to $3.32. Over the last five days, the stock has lost -3.63%. Puma Biotechnology Inc shares have risen nearly 8.69% since the year began. Nevertheless, the stocks have fallen -12.99% over the past one year. While a 52-week high of $4.13 was reached on 01/07/25, a 52-week low of $2.22 was recorded on 04/09/25. SMA at 50 days reached $3.10, while 200 days put it at $2.95.
Levels Of Support And Resistance For PBYI Stock
The 24-hour chart illustrates a support level at 3.18, which if violated will result in even more drops to 3.05. On the upside, there is a resistance level at 3.42. A further resistance level may holdings at 3.53. The Relative Strength Index (RSI) on the 14-day chart is 53.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 44.64%. Stochastics %K at 52.78% indicates the stock is a holding.
How much short interest is there in Puma Biotechnology Inc?
A steep rise in short interest was recorded in Puma Biotechnology Inc stocks on 2025-05-15, dropping by 1445.0 shares to a total of 2.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 2.87 million shares. There was a decline of -0.05%, which implies that there is a negative sentiment for the stock.
